Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2017 | From one generation to the next: the progression of CLL research

Kanti Rai • 14 Aug 2017
iwCLL 2017
Chronic Lymphocytic Leukemia

Kanti Rai, MD, from the Feinstein Institute for Medical Research, Manhasset, NY, provides us an insight into how treatment and research into chronic lymphocytic leukemia (CLL) has evolved over the past years, from a disease with no form of treatment and little interest in research, to one that has various therapy options and clinical trials being conducted. He ends on a hopeful and positive note and believes that the many questions concerning CLL will soon be answered, thanks to the new generation of young doctors and researchers. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.

More from Kanti Rai

9:35
Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells
Kanti Rai • 25 Oct 2018
3:18
Opinion on MRD in CLL: routine use or clinical trials?
Kanti Rai • 25 Oct 2018
1:37
Progress in CLL diagnosis and treatment
Kanti Rai • 25 Oct 2018
5:14
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al. • 29 Feb 2016

Related Videos

1:17
An ongoing Phase I/II study of sonrotoclax + zanubrutinib in patients with treatment-naive CLL/SLL
Piers Patten • 28 Apr 2024
1:51
Should MRD eradication be the goal when treating every patient with CLL?
Dima El-Sharkawi • 28 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
The content of VJHemOnc is intended for healthcare professionals